May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Nicholas DeVito: Duke’s first-line immunotherapy trial for advanced/metastatic CRC is still enrolling
Apr 22, 2025, 14:05

Nicholas DeVito: Duke’s first-line immunotherapy trial for advanced/metastatic CRC is still enrolling

Nicholas DeVitoAssistant Professor of Medicine at the Division of Medical Oncology at Duke University, shared a post on LinkedIn:

“Our first-line immunotherapy (botensilimab/balstilimab) trial for advanced/metastatic colorectal cancer without liver, bone, or brain metastasis is still enrolling!

This trial is supported by Gateway for Cancer Research, Duke CRUSH CRC, and patient philanthropy.

Learn more about the BBOpCo trial here.”